Inozyme Pharma logo

Inozyme Pharma Share Price Today

(NASDAQ: INZY)

Inozyme Pharma share price is $1.19 & ₹103.49 as on 6 Mar 2025, 2.30 'hrs' IST

$1.19

0.07

(6.25%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Inozyme Pharma share price in Dollar and Rupees. Guide to invest in Inozyme Pharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Inozyme Pharma, along with analyst recommendations, forecasts, and comprehensive financials.

Inozyme Pharma share price movements

  • Today's Low: $1.11
    Today's High: $1.20

    Day's Volatility :7.5%

  • 52 Weeks Low: $1.04
    52 Weeks High: $7.80

    52 Weeks Volatility :86.66%

Inozyme Pharma (INZY) Returns

PeriodInozyme Pharma IncSector (Health Care)Index (Russel 2000)
3 Months
-52.02%
3.7%
0.0%
6 Months
-77.2%
-2.8%
0.0%
1 Year
-80.23%
2.5%
0.0%
3 Years
-77.55%
12.9%
-11.6%

Inozyme Pharma (INZY) Key Statistics

in dollars & INR

Previous Close
$1.12
Open
$1.1
Today's High
$1.2
Today's Low
$1.11
Market Capitalization
$71.9M
Today's Volume
$461.0K
52 Week High
$7.795
52 Week Low
$1.04
Revenue TTM
$0.0
EBITDA
$-98.9M
Earnings Per Share (EPS)
$-1.59
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-79.42%

How to invest in Inozyme Pharma Stock (INZY) from India?

It is very easy for Indian residents to invest directly in Inozyme Pharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Inozyme Pharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Inozyme Pharma or INZY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Inozyme Pharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Inozyme Pharma shares which would translate to 0.731 fractional shares of Inozyme Pharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Inozyme Pharma, in just a few clicks!

Returns in Inozyme Pharma (INZY) for Indian investors in Rupees

The Inozyme Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Inozyme Pharma investment value today

Current value as on today

₹24,716

Returns

₹75,284

(-75.28%)

Returns from Inozyme Pharma Stock

₹80,233 (-80.23%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Inozyme Pharma (INZY)

80%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Inozyme Pharma Stock from India on INDmoney has increased by 80% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Inozyme Pharma

  • Adage Capital Partners Gp LLC

    8.03%

  • Pivotal bioVenture Partners Investment Advisor LLC

    7.00%

  • Sofinnova Ventures

    6.66%

  • Affinity Asset Advisors, LLC

    6.18%

  • Rock Springs Capital Management LP

    6.01%

  • BlackRock Inc

    5.93%

Analyst Recommendation on Inozyme Pharma

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Inozyme Pharma(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
12
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Inozyme Pharma Stock (INZY)

What analysts predicted

Upside of 1412.61%

Target:

$18.00

Current:

$1.19

Insights on Inozyme Pharma Stock (Ticker Symbol: INZY)

  • Price Movement

    In the last 3 months, INZY stock has moved down by -53.7%
  • INZY vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 146.7%
  • INZY vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 129.8%

Inozyme Pharma Technicals Summary

Sell

Neutral

Buy

Inozyme Pharma is currently in a neutral trading position according to technical analysis indicators.

Inozyme Pharma (INZY) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Inozyme Pharma Inc logo
-12.5%
-77.2%
-80.23%
-77.55%
-93.22%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Inozyme Pharma Inc logo
NA
NA
NA
-1.51
-0.79
-0.36
NA
1.29
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Inozyme Pharma Inc logo
Buy
$71.9M
-93.22%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Inozyme Pharma

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, as well as patients with end-stage kidney disease receiving hemodialysis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Organization
Inozyme Pharma
Employees
59
CEO
Dr. Douglas A. Treco Ph.D.
Industry
Health Technology

Management People of Inozyme Pharma

NameTitle
Dr. Douglas A. Treco Ph.D.
CEO & Chairman
Mr. Axel Bolte M.B.A., M.Sc.
Co-Founder, Senior Advisor & Director
Mr. Sanjay S. Subramanian M.B.A., M.S.
Senior VP, CFO, Principal Accounting Officer & Corporate Secretary
Dr. Matthew Winton Ph.D.
Senior VP & COO
Dr. Demetrios Braddock M.D., Ph.D.
Co-Founder, Scientific Founder, Member of Scientific Advisory Board & Board Observer
Dr. Soojin Kim Ph.D.
Senior VP & Chief Technical Operations Officer
Dr. Yves Sabbagh Ph.D.
Senior VP, Chief Scientific Officer & Chair of the Scientific Advisory Board
Mr. Stefan Riley
Director of Investor Relations
Ms. Gayle Gironda
Senior VP & Chief People Officer
Mr. Stephen J. Di Palma M.B.A.
Consultant

Important FAQs about investing in INZY Stock from India :

What is Inozyme Pharma share price today?

Inozyme Pharma share price today stands at $1.19, Open: $1.10 ; Previous Close: $1.12 ; High: $1.20 ; Low: $1.11 ; 52 Week High: $7.80 ; 52 Week Low: $1.04.

The stock opens at $1.10, after a previous close of $1.12. The stock reached a daily high of $1.20 and a low of $1.11, with a 52-week high of $7.80 and a 52-week low of $1.04.

Can Indians buy Inozyme Pharma shares?

Yes, Indians can invest in the Inozyme Pharma (INZY) from India.

With INDmoney, you can buy Inozyme Pharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Inozyme Pharma at zero transaction cost.

How can I buy Inozyme Pharma shares from India?

It is very easy to buy Inozyme Pharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Inozyme Pharma (INZY) be purchased?

Yes, you can buy fractional shares of Inozyme Pharma with INDmoney app.

What are the documents required to start investing in Inozyme Pharma stocks?

To start investing in Inozyme Pharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Inozyme Pharma Stock (INZY)?

Today’s highest price of Inozyme Pharma (INZY) is $1.20.

Today’s lowest price of Inozyme Pharma (INZY) is $1.11.

What is today's market capitalisation of Inozyme Pharma?

Today's market capitalisation of Inozyme Pharma INZY is 71.9M

What is the 52 Week High and Low Range of Inozyme Pharma Stock (INZY)?

  • 52 Week High

    $7.80

  • 52 Week Low

    $1.04

What are the historical returns of Inozyme Pharma (INZY)?

  • 1 Month Returns

    -12.5%

  • 3 Months Returns

    -77.2%

  • 1 Year Returns

    -80.23%

  • 5 Years Returns

    -93.22%

Who is the Chief Executive Officer (CEO) of Inozyme Pharma ?

Dr. Douglas A. Treco Ph.D. is the current Chief Executive Officer (CEO) of Inozyme Pharma.